PATENT CLAIM ANALYSIS

Application Number: 16078403
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "299000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver and gastrointestinal diseases.

Claim (Index 2):
The method according to  claim 1 , wherein the disease is bile acid malabsorption, bile acid diarrhea (e.g. primary, secondary bile acid diarrhea), bile reflux gastritis, collagenous colitis, lymphocytic colitis, diversion colitis, indeterminate colitis, bone marrow or stem cell transplant associated graft versus host disease or parenteral nutrition-associated liver disease.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 96.0
- Lexical Diversity: 1.03333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15263033', '16030141', '13402819', '15598734', '14743295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7680241006752052
- 35 USC 102 Novelty (BERT): 0.4966472046401243
- Combined Prediction Score: 0.7408864110716971
- Mean Citation Score: 218.937124
- Max Citation Score: 227.21574
- Similarity Product: 162.52592088864327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test